Emmaus Life Sciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $29.0M | $-56.5M | $1.4M |
| FY2025 | $27.1M | $-63.6M | $2.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $29.0M | $-56.5M | $1.4M |
| FY2025 | $27.1M | $-63.6M | $2.1M |